Better AI Stock: C3.ai vs. Palantir

In This Article:

Key Points

C3.ai (NYSE: AI) and Palantir (NASDAQ: PLTR) represent two different ways to invest in the booming artificial intelligence (AI) market. C3.ai develops data-ingesting AI modules that can be plugged into an organization's existing infrastructure or run as standalone services. Palantir operates two main platforms -- Gotham for its government clients and Foundry for its commercial clients -- that gather data from disparate sources to spot trends and predict future challenges.

C3.ai went public at $42 via a traditional initial public offering (IPO) in December 2020, but it now trades at about $25. It lost its luster as its growth slowed down, it racked up steep losses, and investors fretted over its customer concentration issues. Palantir went public through a direct listing in September 2020, and its stock started trading at $10. Today, it trades at more than $130. The bulls embraced Palantir as it grew rapidly, its profits soared, and it joined the S&P 500 and Nasdaq-100. So is Palantir still a better AI play than C3.ai right now?

An illustration of a digital brain.
Image source: Getty Images.

C3.ai is resolving some of its most pressing issues

C3.ai's AI modules can be installed as on-premises software or via hybrid cloud deployments and public cloud infrastructure platforms to automate and accelerate custom tasks. It originally only provided subscription-based services, but in late 2022, it rolled out a consumption-based fee option to attract more customers.

In its fiscal 2023 (which ended in April 2023), C3.ai's revenue only rose 6% as macroeconomic headwinds drove many of its customers to rein in their spending, it faced tougher competition, and its consumption-based option cannibalized its subscription sales. It also faced the looming expiration at the end of its fiscal 2025 of a joint venture with Baker Hughes that accounted for more than 30% of its revenue. Those challenges, along with a declining gross margin and ongoing losses, spooked investors.

However, C3.ai's revenue rose 16% in its fiscal 2024 and grew by 25% in its fiscal 2025. That acceleration was driven by its new generative AI modules; its strategic partnerships with Microsoft, Amazon, and McKinsey; and fresh federal contracts. It expects its revenue to rise by 15% to 25% in fiscal 2026, while analysts on average anticipate 20% growth.

C3.ai also recently renewed its joint venture with Baker Hughes for another three years. That extension should buy it more time to further diversify its customer base. But it's still expected to stay unprofitable for the foreseeable future -- and it isn't a screaming bargain at 8 times this year's expected sales. So while some green shoots are finally appearing, C3.ai's stock probably won't rebound to its IPO price until it meaningfully widens its moat and narrows its losses.